ClinConnect ClinConnect Logo
Search / Trial NCT06013813

Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI

Launched by INSTITUTO NACIONAL DE CARDIOLOGIA IGNACIO CHAVEZ · Aug 22, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stemi Distal Radial Access Conventional Radial Access Mace

ClinConnect Summary

This clinical trial is studying two different ways of accessing the radial artery (in the wrist) to treat patients who have suffered a heart attack known as STEMI (ST Elevation Myocardial Infarction). The trial compares the conventional method of accessing the radial artery with a newer approach called distal radial access. The main goal is to find out if using the distal method leads to fewer major heart-related problems within 30 days after the procedure, while still ensuring that the procedure is successful.

To participate, patients must be diagnosed with STEMI and agree to undergo a procedure called PCI (Percutaneous Coronary Intervention) to open blocked arteries. They will need to sign a consent form and will be randomly assigned to either the conventional or distal approach. Some patients may not be eligible due to certain health conditions, like severe heart issues or previous surgeries. Overall, this trial aims to determine if the distal approach is just as safe and effective as the conventional method, which could help improve treatment options for future heart attack patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • STEMI patients underwent PCI.
  • Patent radial access (distal and conventional)
  • Patients who agree to participate in the study and sign the informed consent form.
  • Exclusion Criteria:
  • Cardiogenic shock.
  • Previous coronary artery bypass grafting (CABG).
  • Absence of palpable radial pulse.
  • Arteriovenous fistula for hemodialysis.
  • Previous radial artery occlusion.

About Instituto Nacional De Cardiologia Ignacio Chavez

The Instituto Nacional de Cardiología Ignacio Chávez is a leading research institution in Mexico, dedicated to advancing cardiovascular health through innovative clinical trials and medical research. Renowned for its commitment to excellence in patient care and scientific inquiry, the institute focuses on developing new therapeutic interventions and improving existing treatments for cardiovascular diseases. By fostering collaboration among healthcare professionals, researchers, and academic institutions, the Instituto Nacional de Cardiología Ignacio Chávez aims to enhance clinical outcomes and contribute to the global understanding of cardiovascular health.

Locations

Mexico City, , Mexico

Patients applied

0 patients applied

Trial Officials

Guering Eid Lidt, PhD

Study Chair

Guering Eid-Lidt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported